...
search icon
  • Apple, Inc AAPL
  • S&P 500 ETF Trust SPDR SPY
  • Alphabet Inc. - Class A Shares GOOGL
  • Microsoft Corporation MSFT
  • Meta Platforms Inc META
  • Netflix, Inc. NFLX
  • Amazon.com Inc. AMZN
  • Spotify Technology SA SPOT
    hcm-img

    HUTCHMED DRC, Common Stock

    HCM

    NSQ

    $13.76

    +$0.02

    (0.15%)

    1D
    Industry: Pharmaceuticals Sector: Health Care

    Analyst Forecast

    Overview Returns Financials Ratios News FAQs

    Price Chart

    Key Metrics

    Market Cap info-icon
    This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
     $2.35B
    P/E Ratio info-icon
    This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
     68.8
    Volume info-icon
    This is the total number of shares traded during the most recent trading day.
     0
    Avg Volume info-icon
    This is the average number of shares traded during the most recent 30 days.
     0
    Dividend Yield info-icon
    This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
     0.00%
    Beta info-icon
    This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
     0.72
    52-week Range info-icon
    This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
    $11.51 L
    $21.92 H
    $13.76

    About HUTCHMED DRC, Common Stock

    HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies to treat cancer and immunological diseases in Hong Kong, the United States, and internationally. The company offers Fruquintinib, a selective and potent oral inhibitor of vascular endothelial growth factor receptors for treatment of colorectal cancer (CRC), breast cancer, gastric cancer (GC), microsatellite stable-CRC endometrial cancer (EMC), non-small cell lung cancer (NSCLC), renal cell carcinoma (RCC), endometrial cancer (EMC); and Savolitinib, a potent and selective inhibitor of mesenchymal-epithelial transition receptor to treat NSCLC, papillary RCC, and GC. It also develops Surufatinib to trea pancreatic neuroendocrine tumor (NET), non pancreatic NET, and pancreatic ductal adenocarcinoma; Sovleplenib, to treat immune thrombocytopenic purpura and warm autoimmune hemolytic anemia; and Tazemetostat, a treatment for epithelioid sarcoma and follicular lymphoma; Fanregratinib that treats intrahepatic cholangiocarcinoma; and Ranosidenib, a novel dual-inhibitor of dehydrogenase-1 and isocitrate dehydrogenase-2 enzymes to treat acute myeloid leukemia (AML). In addition, the company is developing HMPL-760, which is in phase I and II clinical trial to treat relapsed and/or refractory diffuse large B cell lymphoma, chronic lymphocytic leukemia, small lymphocytic lymphoma, and other B-NHL; HMPL-506 to treat Mixed-lineage leukemia-rearrange/rearrangement and nucleophosmin 1-mutantAML. It has collaboration agreements with AstraZeneca AB (publ), Lilly (Shanghai) Management Company Limited, Takeda, BeiGene Ltd., Inmagene Biopharmaceuticals Co. Ltd., Innovent Biologics Co., Inc., and Epizyme, Inc., and Epizyme, Inc. The company was formerly known as Hutchison China MediTech Limited and changed its name to HUTCHMED (China) Limited in May 2021. HUTCHMED (China) Limited was incorporated in 2000 and is headquartered in Hong Kong, Hong Kong. more

    Industry: PharmaceuticalsSector: Health Care

    Returns

    Time FrameHCMSectorS&P500
    1-Week Return9.82%0.44%0.24%
    1-Month Return-9.11%-7.69%-7.32%
    3-Month Return-3.1%-3.35%-12.05%
    6-Month Return-29.15%-11.09%-9.73%
    1-Year Return-16.35%-2.13%5.05%
    3-Year Return-16.81%-1.18%20.03%
    5-Year Return-28.15%34.44%83.31%
    10-Year Return2.69%84.87%153.54%

    Financials

    Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
    Total Revenue227.98M356.13M426.41M838.00M630.20M[{"date":"2020-12-31","value":27.2,"profit":true},{"date":"2021-12-31","value":42.5,"profit":true},{"date":"2022-12-31","value":50.88,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":75.2,"profit":true}]
    Cost of Revenue188.52M258.23M311.10M384.45M348.88M[{"date":"2020-12-31","value":49.04,"profit":true},{"date":"2021-12-31","value":67.17,"profit":true},{"date":"2022-12-31","value":80.92,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":90.75,"profit":true}]
    Gross Profit39.46M97.89M115.31M453.55M281.32M[{"date":"2020-12-31","value":8.7,"profit":true},{"date":"2021-12-31","value":21.58,"profit":true},{"date":"2022-12-31","value":25.42,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":62.03,"profit":true}]
    Gross Margin17.31%27.49%27.04%54.12%44.64%[{"date":"2020-12-31","value":31.98,"profit":true},{"date":"2021-12-31","value":50.79,"profit":true},{"date":"2022-12-31","value":49.96,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":82.48,"profit":true}]
    Operating Expenses236.13M426.21M523.00M436.23M321.93M[{"date":"2020-12-31","value":45.15,"profit":true},{"date":"2021-12-31","value":81.49,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":83.41,"profit":true},{"date":"2024-12-31","value":61.55,"profit":true}]
    Operating Income(188.95M)(336.46M)(409.77M)18.38M(40.61M)[{"date":"2020-12-31","value":-1028.28,"profit":false},{"date":"2021-12-31","value":-1831.06,"profit":false},{"date":"2022-12-31","value":-2230.04,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-221.01,"profit":false}]
    Total Non-Operating Income/Expense9.38M114.06M6.22M75.32M76.71M[{"date":"2020-12-31","value":8.23,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":5.45,"profit":true},{"date":"2023-12-31","value":66.03,"profit":true},{"date":"2024-12-31","value":67.25,"profit":true}]
    Pre-Tax Income(189.73M)(215.74M)(410.42M)58.31M(1.11M)[{"date":"2020-12-31","value":-325.4,"profit":false},{"date":"2021-12-31","value":-370,"profit":false},{"date":"2022-12-31","value":-703.89,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-1.9,"profit":false}]
    Income Taxes4.83M11.92M(283.00K)4.51M7.19M[{"date":"2020-12-31","value":40.52,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-2.37,"profit":false},{"date":"2023-12-31","value":37.83,"profit":true},{"date":"2024-12-31","value":60.35,"profit":true}]
    Income After Taxes(194.56M)(227.66M)(410.14M)53.80M(8.30M)[{"date":"2020-12-31","value":-361.65,"profit":false},{"date":"2021-12-31","value":-423.16,"profit":false},{"date":"2022-12-31","value":-762.35,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-15.43,"profit":false}]
    Income From Continuous Operations(115.52M)(167.04M)(360.39M)101.09M38.17M[{"date":"2020-12-31","value":-114.27,"profit":false},{"date":"2021-12-31","value":-165.23,"profit":false},{"date":"2022-12-31","value":-356.49,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":37.76,"profit":true}]
    Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
    Net Income(194.56M)(227.66M)(410.14M)100.78M37.73M[{"date":"2020-12-31","value":-193.06,"profit":false},{"date":"2021-12-31","value":-225.9,"profit":false},{"date":"2022-12-31","value":-406.96,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":37.44,"profit":true}]
    EPS (Diluted)(0.96)(0.97)(2.68)0.97-[{"date":"2020-12-31","value":-98.68,"profit":false},{"date":"2021-12-31","value":-99.6,"profit":false},{"date":"2022-12-31","value":-276.29,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":"-","profit":true}]

    Ratios

    Liquidity

    These ratios help you determine the liquidity of the company. Higher is better.

    HCM
    Cash Ratio 2.22
    Current Ratio 2.83
    Quick Ratio 2.70

    Asset Efficiency

    These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

    HCM
    ROA (LTM) -2.14%
    ROE (LTM) 5.04%

    Liabilities

    These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

    HCM
    Debt Ratio Lower is generally better. Negative is bad. 0.39
    Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.60

    Valuation

    These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

    HCM
    Trailing PE 68.80
    Forward PE 44.84
    P/S (TTM) 3.73
    P/B 3.10
    Price/FCF 145
    EV/R 2.53
    EV/Ebitda 113.06
    PEG NM

    Discover more

    Tsla

    Tesla, Inc.
    aaple

    Apple, Inc.
    GOOGL

    Alphabet Inc. - Class A Shares
    META

    Meta Platforms Inc
    AMZN

    Amazon.com Inc.
    Microsoft

    Microsoft Corporation
    NVDA

    NVIDIA Corporation
    BRK

    Berkshire Hathaway Inc. Hld B
    LLY

    Eli Lilly and Company

    FAQs

    What is HUTCHMED DRC share price today?

    HUTCHMED DRC (HCM) share price today is $13.76

    Can Indians buy HUTCHMED DRC shares?

    Yes, Indians can buy shares of HUTCHMED DRC (HCM) on Vested. To buy HUTCHMED DRC from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in HCM stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

    Can Fractional shares of HUTCHMED DRC be purchased?

    Yes, you can purchase fractional shares of HUTCHMED DRC (HCM) via the Vested app. You can start investing in HUTCHMED DRC (HCM) with a minimum investment of $1.

    How to invest in HUTCHMED DRC shares from India?

    You can invest in shares of HUTCHMED DRC (HCM) via Vested in three simple steps:

    • Click on Sign Up or Invest in HCM stock at the top of this page
    • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
    • Transfer USD funds to your US Brokerage account and start investing in HUTCHMED DRC shares
    What is HUTCHMED DRC 52-week high and low stock price?

    The 52-week high price of HUTCHMED DRC (HCM) is $21.92. The 52-week low price of HUTCHMED DRC (HCM) is $11.51.

    What is HUTCHMED DRC price-to-earnings (P/E) ratio?

    The price-to-earnings (P/E) ratio of HUTCHMED DRC (HCM) is 68.8

    What is HUTCHMED DRC price-to-book (P/B) ratio?

    The price-to-book (P/B) ratio of HUTCHMED DRC (HCM) is 3.10

    What is the Market Cap of HUTCHMED DRC?

    The market capitalization of HUTCHMED DRC (HCM) is $2.35B

    What is HUTCHMED DRC’s stock symbol?

    The stock symbol (or ticker) of HUTCHMED DRC is HCM

    Feedback

    Signup to access all features and start your US investing journey!

    • Open your account in minutes
    • Take your portfolio global, starting at just $1
    Get started

    Add ticker to compare

    Scroll to Top